Alterity Therapeutics (ATHE) Goodwill & Intangibles (2010 - 2020)
Alterity Therapeutics (ATHE) recorded quarterly Goodwill & Intangibles of $119.1 million in Q4 2020, up 23.74% quarter-over-quarter from $96.3 million in Q2 2020.
Alterity Therapeutics (ATHE) Goodwill & Intangibles (2010 - 2020) Analysis & Trends
Alterity Therapeutics' Goodwill & Intangibles history runs 3 years deep, the most recent figure standing at $119.1 million for Q4 2020.
- In Q4 2020, Goodwill & Intangibles changed N/A year-over-year to $119.1 million; the TTM figure through Dec 2020 stood at $119.1 million (changed N/A YoY), while the FY2020 annual figure was $96.3 million, changed N/A from the prior year.
- Goodwill & Intangibles was $119.1 million for Q4 2020 at Alterity Therapeutics, up from $96.3 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $119.1 million in Q4 2020 to a low of $96.3 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 119.13 Mn |
| Jun 30, 2020 | 96.27 Mn |
| Jun 30, 2011 | 7.36 Mn |
| Jun 30, 2010 | 4.62 Mn |